• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应以显著的个体变化作为基于锚定物的患者报告结局评分的有意义变化的下限估计值。

Significant individual change should be used as a lower bound for anchor based estimates of meaningful change on patient-reported outcome scores.

机构信息

Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, USA.

Centre for Patient Reported Outcomes Research, Department of Applied Health Sciences, University of Birmingham, Edgbaston Birmingham, UK, Edgbaston, Birmingham, UK.

出版信息

Qual Life Res. 2024 Dec;33(12):3223-3228. doi: 10.1007/s11136-024-03788-9. Epub 2024 Sep 28.

DOI:10.1007/s11136-024-03788-9
PMID:39340723
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11599412/
Abstract

Interpretation of patient-reported outcome (PRO) scores has been supported by identifying score thresholds or ranges that indicate clinical importance. There has been a recent focus on the estimation of meaningful within patient change (MWPC). While much attention has been focused on anchor-based methods, some researchers prefer that a lower bound to these estimates should exceed a change score that could be observed due to measurement error alone as a safeguard against misclassifying individual patients as changed when they have not. The standard error of measurement (SEM) is often used as the lower bound of anchor estimates. Here, we argue that the SEM is not an the best lower bound for MWPCs. Instead, statistically significant individual change as calculated by the reliable change index (RCI) should be used as the lower bound. Our argument is based on two points. First, conceptually, the SEM does not provide specific enough information to serve as a lower bound for MWPCs, which should be based on the level of observed score change that is unlikely to be due to chance alone. Second, the SEM is not appropriate for direct application to observed scores, and requires a multiplier when examining observed change instead of true change. We conclude with recommendations for using the RCI with a thoughtful range of p-values in combination with anchor estimates.

摘要

患者报告结局(PRO)评分的解释得到了确定评分阈值或范围的支持,这些范围表明了临床重要性。最近人们关注的重点是估计有意义的患者内变化(MWPC)。虽然锚定方法得到了广泛关注,但一些研究人员希望这些估计的下限应该超过由于测量误差单独导致的变化得分,以防止将没有变化的个体患者错误地归类为有变化。测量误差(SEM)通常用作锚定估计的下限。在这里,我们认为 SEM 不是 MWPC 的最佳下限。相反,应该使用可靠变化指数(RCI)计算的统计学上显著的个体变化作为下限。我们的论点基于两点。首先,从概念上讲,SEM 不能提供足够具体的信息作为 MWPC 的下限,MWPC 的下限应该基于不太可能仅仅由于机会导致的观察到的评分变化水平。其次,SEM 不适合直接应用于观察到的分数,并且在检查观察到的变化而不是真实变化时需要一个乘数。我们的结论是,建议使用 RCI 并结合深思熟虑的 p 值范围,以及锚定估计。

相似文献

1
Significant individual change should be used as a lower bound for anchor based estimates of meaningful change on patient-reported outcome scores.应以显著的个体变化作为基于锚定物的患者报告结局评分的有意义变化的下限估计值。
Qual Life Res. 2024 Dec;33(12):3223-3228. doi: 10.1007/s11136-024-03788-9. Epub 2024 Sep 28.
2
Meaningful change threshold estimation for the non-small cell lung cancer symptom assessment questionnaire (NSCLC-SAQ): psychometric analysis from a phase 3 trial (LIBRETTO-431).非小细胞肺癌症状评估问卷(NSCLC-SAQ)的有意义变化阈值估计:来自3期试验(LIBRETTO-431)的心理测量分析
Qual Life Res. 2025 Apr;34(4):1137-1146. doi: 10.1007/s11136-025-03895-1. Epub 2025 Jan 23.
3
Determining Thresholds for Meaningful Change for the Headache Impact Test (HIT-6) Total and Item-Specific Scores in Chronic Migraine.确定慢性偏头痛头痛影响测试(HIT-6)总分和项目特异性评分的有意义变化阈值。
Headache. 2020 Oct;60(9):2003-2013. doi: 10.1111/head.13946. Epub 2020 Aug 30.
4
Comparison of anchor-based methods for estimating thresholds of meaningful within-patient change using simulated PROMIS PF 20a data under various joint distribution characteristic conditions.基于锚定的方法在不同联合分布特征条件下模拟 PROMIS PF 20a 数据估计有意义的患者内变化阈值的比较。
Qual Life Res. 2023 May;32(5):1277-1293. doi: 10.1007/s11136-022-03285-x. Epub 2022 Nov 13.
5
What Are the Minimum Clinically Important Differences in SF-36 Scores in Patients with Orthopaedic Oncologic Conditions?骨科肿瘤患者 SF-36 评分的最小临床重要差异是多少?
Clin Orthop Relat Res. 2020 Sep;478(9):2148-2158. doi: 10.1097/CORR.0000000000001341.
6
What Are the Minimum Clinically Important Difference, Substantial Clinical Benefit, and Patient-Acceptable Symptom State Thresholds for the Modified Harris Hip Score and International Hip Outcome Tool 12 Among Patients Who Undergo Periacetabular Osteotomy?对于接受髋臼周围截骨术的患者,改良Harris髋关节评分和国际髋关节结果工具12的最小临床重要差异、显著临床益处及患者可接受的症状状态阈值分别是多少?
Clin Orthop Relat Res. 2025 Feb 12. doi: 10.1097/CORR.0000000000003393.
7
Establishing clinically meaningful within-individual improvement thresholds for eight patient-reported outcome measures in people with relapsing-remitting multiple sclerosis.确立复发缓解型多发性硬化患者 8 项患者报告结局测量指标的临床有意义个体内改善阈值。
J Patient Rep Outcomes. 2023 Jul 4;7(1):61. doi: 10.1186/s41687-023-00594-8.
8
Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®).确定患者报告的不良事件通用术语标准(PRO-CTCAE®)中恶化情况的有意义的个体水平变化阈值。
Qual Life Res. 2025 Feb;34(2):495-507. doi: 10.1007/s11136-024-03819-5. Epub 2024 Nov 6.
9
Longitudinal validity of the Hyperhidrosis Quality of Life Index (HidroQoL©) in a phase IIIb clinical trial population with hyperhidrosis: responsiveness and meaningful change.多汗症生活质量指数(HidroQoL©)在IIIb期多汗症临床试验人群中的纵向效度:反应性和有意义的变化
Br J Dermatol. 2025 Feb 18;192(3):450-457. doi: 10.1093/bjd/ljae415.
10
Patient-reported outcomes in non-small cell lung cancer: psychometric evaluation of the PROMIS PF-SF 8c and NSCLC-SAQ in two phase 3 clinical trials.非小细胞肺癌患者报告的结局:两项3期临床试验中PROMIS身体功能简表8c和非小细胞肺癌特异性生存质量量表的心理测量学评估
Qual Life Res. 2025 Mar;34(3):751-762. doi: 10.1007/s11136-024-03846-2. Epub 2024 Dec 5.

引用本文的文献

1
Internal consistency, construct validity, and responsiveness of the MRC Prion Disease Rating Scale.医学研究委员会朊病毒病评定量表的内部一致性、结构效度和反应性。
J Patient Rep Outcomes. 2025 May 6;9(1):49. doi: 10.1186/s41687-025-00884-3.
2
Longitudinal validation of the PROMIS-16 in a sample of adults in the United States with back pain.PROMIS-16在美国背痛成人样本中的纵向验证。
Qual Life Res. 2025 Jan;34(1):35-42. doi: 10.1007/s11136-024-03826-6. Epub 2024 Nov 6.

本文引用的文献

1
Likely change indexes do not always index likely change; moreover, there is no need for them.可能变化指数并不总是能指示可能的变化;此外,也没有这样做的必要。
Qual Life Res. 2023 May;32(5):1401-1402. doi: 10.1007/s11136-022-03314-9. Epub 2022 Dec 5.
2
How strong should my anchor be for estimating group and individual level meaningful change? A simulation study assessing anchor correlation strength and the impact of sample size, distribution of change scores and methodology on establishing a true meaningful change threshold.用于估计群组和个体水平有意义变化的锚应该有多强?一项模拟研究评估了锚相关性强度,以及样本量、变化分数分布和方法对建立真实有意义变化阈值的影响。
Qual Life Res. 2023 May;32(5):1255-1264. doi: 10.1007/s11136-022-03286-w. Epub 2022 Nov 19.
3
Likely change indexes improve estimates of individual change on patient-reported outcomes.可能改变指标可改善患者报告结局个体变化的估计。
Qual Life Res. 2023 May;32(5):1341-1352. doi: 10.1007/s11136-022-03200-4. Epub 2022 Aug 3.
4
Guest Editors' Introduction to the Invited Special Section.特邀专题客座编辑引言
Psychometrika. 2021 Sep;86(3):671-673. doi: 10.1007/s11336-021-09795-w.
5
Between-group minimally important change versus individual treatment responders.组间最小重要变化与个体治疗反应者。
Qual Life Res. 2021 Oct;30(10):2765-2772. doi: 10.1007/s11136-021-02897-z. Epub 2021 Jun 15.
6
Promoting effective use of patient-reported outcomes in clinical practice: themes from a "Methods Tool kit" paper series.促进患者报告结局在临床实践中的有效应用:“方法工具包”系列论文的主题。
J Clin Epidemiol. 2020 Jun;122:153-159. doi: 10.1016/j.jclinepi.2020.01.022. Epub 2020 Feb 13.
7
Can Methods Developed for Interpreting Group-level Patient-reported Outcome Data be Applied to Individual Patient Management?用于解释群组水平患者报告结局数据的方法能否应用于个体患者管理?
Med Care. 2019 May;57 Suppl 5 Suppl 1(Suppl 5 1):S38-S45. doi: 10.1097/MLR.0000000000001111.
8
Moving from significance to real-world meaning: methods for interpreting change in clinical outcome assessment scores.从统计学意义到实际意义的转变:临床结局评估评分变化的解释方法。
Qual Life Res. 2018 Jan;27(1):33-40. doi: 10.1007/s11136-017-1616-3. Epub 2017 Jun 15.
9
Minimally important differences for Patient Reported Outcomes Measurement Information System pain interference for individuals with back pain.患者报告结局测量信息系统中背痛患者疼痛干扰的最小重要差异。
J Pain Res. 2016 Apr 27;9:251-5. doi: 10.2147/JPR.S93391. eCollection 2016.
10
Methods for interpreting change over time in patient-reported outcome measures.患者报告结局测量中随时间变化的解读方法。
Qual Life Res. 2013 Apr;22(3):475-83. doi: 10.1007/s11136-012-0175-x. Epub 2012 Apr 17.